Shandong Xinhua Pharmaceutical Company Limited’s Net Profit Rose 32% in First Three Quarters of 2023

Shandong Xinhua Pharmaceutical Company Limited (山东新华制药股份有限公司) (000756.SZ) reported a net profit of 400.3 million yuan in the first three quarters of 2023, up 32% year-on-year.

Meanwhile, the company posted 6.5 billion yuan in revenue, up 19.1% year-on-year.

At the end of the reporting period, it had 7.9 billion yuan in total assets and 3.2 billion yuan in total liabilities, with a liability-to-asset ratio of 40.7%.